Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Gross Profit (2016 - 2017)

Lisata Therapeutics (LSTA) has disclosed Gross Profit for 8 consecutive years, with -$119600.0 as the latest value for Q1 2017.

  • For the quarter ending Q1 2017, Gross Profit fell 109.48% year-over-year to -$119600.0, compared with a TTM value of $2.8 million through Mar 2017, down 26.92%, and an annual FY2016 reading of $4.1 million, up 78.11% over the prior year.
  • Gross Profit was -$119600.0 for Q1 2017 at Lisata Therapeutics, down from $931442.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $7.2 million in Q4 2015 and bottomed at -$5.8 million in Q2 2015.
  • Average Gross Profit over 5 years is -$446017.5, with a median of $131823.0 recorded in 2013.
  • The sharpest move saw Gross Profit crashed 3052.89% in 2014, then skyrocketed 742.38% in 2016.
  • Year by year, Gross Profit stood at $734050.0 in 2013, then plummeted by 666.45% to -$4.2 million in 2014, then surged by 274.08% to $7.2 million in 2015, then crashed by 87.13% to $931442.0 in 2016, then crashed by 112.84% to -$119600.0 in 2017.
  • Business Quant data shows Gross Profit for LSTA at -$119600.0 in Q1 2017, $931442.0 in Q4 2016, and $706265.0 in Q3 2016.